Improvement in life expectancy in the UK is a significant strategic issue for the UK Government and the economy and is currently poorly understood. As a consequence, it is important to study both the drivers enhancing life expectancy e.g. medical advances and social change and the inhibitors e.g. aspects of lifestyle and delays in development and delivery of treatment interventions.
The Panel takes account of:
The Panel is unconstrained in the conduct and communication of its work by any particular commercial interest. Its conclusions will be openly disseminated, with the intention of promoting public interest in the factors that influence life expectancy.
"Such statistics and research keep us up to date about the health and condition of the people, help to evaluate the services available to them and to plan for the future."